Brief: Inhibikase Therapeutics Announces Appointment Of David Mcintyre As CFO
14/04/2025 15:09
April 14 (Reuters) - Inhibikase Therapeutics Inc IKT.O: INHIBIKASE THERAPEUTICS ANNOUNCES APPOINTMENT OF DAVID MCINTYRE AS CHIEF FINANCIAL OFFICER INHIBIKASE THERAPEUTICS INC - APPOINTMENT OF DAVID MCINTYRE AS CHIEF FINANCIAL OFFICER, EFFECTIVE APRIL 14, 2025 Source text: ID:nGNX5q06tF Further company coverage: IKT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inhibikase Therapeutics
See all newsBrief: Inhibikase Therapeutics Appoints Scott Wasserman To Board Of Directors
Inhibikase Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Inhibikase Q2 net loss widens on higher R&D, SG&A costs
Inhibikase Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Inhibikase Therapeutics Prices Public Offering Of 46 Million Shares At $1.45 Per Share